New Search

If you are not happy with the results below please do another search

Search
Generic filters

50 search results for:

14

Lilly, Merck and Bayer Back a New Composer for Autoimmune Therapies

Seattle-based Mozart Therapeutics closed on a $55 million Series A financing round, led by seed financier ARCH Venture Partners along with Sofinnova Partners. Additional investors were Eli Lilly and Company, MRL Ventures Fund, an early-stage fund run by Merck & Co., Leaps by Bayer, Altitude Life Science Ventures, and Alexandria Venture Investments.